https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Recent Results Cancer Res. 2009;179:301-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Recent Results Cancer Res. 2009;179:301-192009-01-01 00:00:002009-01-01 00:00:00Current concepts in the management of retroperitoneal soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-01 / Acta Oncol 2009;48(3):452-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-01 / Acta Oncol 2009;48(3):452-62009-01-01 00:00:002009-01-01 00:00:00Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-17 / Clin. Rheumatol. 2009 Apr;28(4):397-4022008-12-17 00:00:002019-02-15 09:17:37The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-13 / Cancer Immunol. Immunother. 2009 Dec;58(12):1935-92008-12-13 00:00:002008-12-13 00:00:00Mechanisms of murine dendritic cell antitumor dysfunction in aging
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-06 / Gynecol. Oncol. 2009 Feb;112(2):384-82008-12-06 00:00:002008-12-06 00:00:00Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-04 / Lung Cancer 2009 Jul;65(1):1-82008-12-04 00:00:002019-02-15 08:34:57Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-12-01 / Int J Hyperthermia 2008 Dec;24(8):649-622008-12-01 00:00:002019-02-15 09:17:39Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-28 / Cancer Lett. 2008 Nov;271(2):333-412008-11-28 00:00:002019-02-15 09:16:51Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-27 / Pigment Cell Melanoma Res 2009 Feb;22(1):30-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-27 / Pigment Cell Melanoma Res 2009 Feb;22(1):30-412008-11-27 00:00:002019-02-15 09:19:13Dendritic cells in the skin–potential use for melanoma treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-26 / Clin. Vaccine Immunol. 2009 Feb;16(2):233-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-26 / Clin. Vaccine Immunol. 2009 Feb;16(2):233-402008-11-26 00:00:002019-02-15 09:15:03Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection
